🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 52 week, single center, randomized, double-blind, placebo-control...
Status
Recruiting
Location
Hospital for Special Surgery
Start Date
2019-07-29
Trial ID
NCT03844061
Treatments Being Tested
The purpose of thie study is to evaluate the safety, tolerability, immunoge...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2002-02
Trial ID
NCT00657007
This two year study will evaluate the effects of giving belimumab (Benlysta...
Status
Recruiting
Location
Feinstein Institute
Start Date
2020-09-15
Trial ID
NCT03543839
Treatments Being Tested
This is intended to be an initial "proof-of-concept" study to show feasibil...
Status
Completed
Location
UAB Lung Health Center
Start Date
2018-08-09
Trial ID
NCT03244059
The main clinical study will be a randomized, double-blind, placebo-control...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2013-04
Trial ID
NCT01762852
Treatments Being Tested
Chronic immune thrombocytopenia (ITP) is a longterm disease in which the bl...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT01440361
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of 3 diffe...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2003-12
Trial ID
NCT00071812
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-02-19
Trial ID
NCT01632241
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, tolerability...
Status
Completed
Location
OMI, Organización Médica de Investigación
Start Date
2007-05
Trial ID
NCT00424476
Treatments Being Tested
This study investigates the efficacy and safety of belimumab compared to pl...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2023-09-13
Trial ID
NCT05878717